Article
The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
Clinical science (London, England : 1979) - 1 Jul 2000
Völzke H, Hertwig S, Rettig R, Motz W
Abstract excerpt
The therapeutic benefit of percutaneous transluminal coronary angioplasty (PTCA) is limited by restenosis in 30-40% of patients. The underlying mechanisms are currently not well understood. Besides clinical and angiographic variables, genetic factors may be involved. In the present study, we investigated the associations between the angiotensinogen T174M and M235T, the angiotensin I-converting enzyme (ACE) I/D...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
